From: Safety analysis of romiplostim, eltrombopag, and avatrombopag post-market approval: a pharmacovigilance study based on the FDA Adverse Event Reporting System
Drug
Number of Reports of Target AEs
Number of Reports of Other AEs
Total
Target Drug
a
b
a + b
Other Drugs
c
d
c + d
a + c
b + d
a + b + c + d